Brain Prize Laureate Will Donate Some Winnings to Anti-Brexit Group

Alzheimer’s researcher John Hardy calls the departure “an unmitigated disaster” for science and healthcare in Britain.

Written byShawna Williams
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

EU flag with hole in shape of UKISTOCK, ANDREJ_KAt a press conference today (March 6), one of the four winners of this year’s Brain Prize, University College London neuroscientist John Hardy, turned attention to the impact of Britain’s impending exit from the European Union on science and healthcare in the country. The expected exodus of healthcare workers from other European countries will strain the ability of the U.K.’s National Health Service to care for the growing number of patients with dementia, Hardy predicts.

As reported in The Guardian, Hardy shares the €1 million prize with Bart De Strooper, also of University College London; Michel Goedert of the Medical Research Council Laboratory of Molecular Biology in Cambridge, U.K.; and Christian Haass of the Ludwig-Maximilians-University in Munich, for their discoveries on the mechanisms underlying Alzheimer’s disease.

“When you go around the hospitals, so many of the geriatricians and neurologists are Europeans, and the nurses and carers,” Hardy said during the press conference (via The Guardian). “As a society we’re not doing very well, and the indications are we’re going to do even worse.” The BBC reports that he plans to donate about €5,000 to groups striving to keep Britain in the E.U.

Hardy is far from the first to predict ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • Shawna was an editor at The Scientist from 2017 through 2022. She holds a bachelor’s degree in biochemistry from Colorado College and a graduate certificate in science communication from the University of California, Santa Cruz. Previously, she worked as a freelance editor and writer, and in the communications offices of several academic research institutions. As news director, Shawna assigned and edited news, opinion, and in-depth feature articles for the website on all aspects of the life sciences. She is based in central Washington State, and is a member of the Northwest Science Writers Association and the National Association of Science Writers.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies